AU8444475A - Eburnamenine derivatives - Google Patents

Eburnamenine derivatives

Info

Publication number
AU8444475A
AU8444475A AU84444/75A AU8444475A AU8444475A AU 8444475 A AU8444475 A AU 8444475A AU 84444/75 A AU84444/75 A AU 84444/75A AU 8444475 A AU8444475 A AU 8444475A AU 8444475 A AU8444475 A AU 8444475A
Authority
AU
Australia
Prior art keywords
eburnamenine derivatives
eburnamenine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU84444/75A
Other versions
AU502845B2 (en
Inventor
Csaba Szantay
Lajos Szabo
Gyorgy Kalaus
Egon Karpati
Laszlo Szporny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of AU8444475A publication Critical patent/AU8444475A/en
Application granted granted Critical
Publication of AU502845B2 publication Critical patent/AU502845B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU84444/75A 1968-07-24 1975-09-01 Eburnamenine derivatives Expired AU502845B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUEE001547 1968-07-24

Publications (2)

Publication Number Publication Date
AU8444475A true AU8444475A (en) 1977-03-10
AU502845B2 AU502845B2 (en) 1979-08-09

Family

ID=10995263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84444/75A Expired AU502845B2 (en) 1968-07-24 1975-09-01 Eburnamenine derivatives

Country Status (8)

Country Link
AT (1) AT293432B (en)
AU (1) AU502845B2 (en)
CH (1) CH532556A (en)
DE (1) DE1934809A1 (en)
FR (1) FR2013568A1 (en)
GB (1) GB1274521A (en)
NL (1) NL6911272A (en)
PL (1) PL88879B1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
DK165284A (en) * 1984-03-23 1985-09-24 Cheminova As BIOCID, NAME FUNGICID AND / OR BACTERICID AGENT
DE3709414C1 (en) * 1987-03-21 1988-02-18 Bayer Ag Process for the preparation of methyl dithiocarbazate
CH686642A5 (en) * 1993-07-27 1996-05-15 Sylvia Hover Spectacle lens.
US6025514A (en) * 1996-11-07 2000-02-15 Bayer Corporation Process for preparing methyl dithiocarbazinate by reacting methyl bromide with the reaction product of carbon disulfide, hydrazine and an adjunct base
US5877339A (en) * 1996-11-07 1999-03-02 Bayer Corporation Process for preparing methyl dithiocarbazinate by reacting methyl bromide with the reaction product of carbon disulfide and hydrazine in an aqueous medium
US5861526A (en) * 1996-11-07 1999-01-19 Bayer Corporation Process for reducing dithiocarbazinate buildup in the preparation of methyl dithiocarbazinate
CA2218853C (en) * 1996-11-07 2008-04-22 Bayer Corporation A process for preparing methyl dithiocarbazinate by reacting methyl bromide with the reaction product of carbon disulfide, hydrazine and an adjunct base
WO2011093401A1 (en) 2010-01-27 2011-08-04 三菱レイヨン株式会社 Novel chain transfer agent and emulsion polymerization using same

Also Published As

Publication number Publication date
AU502845B2 (en) 1979-08-09
AT293432B (en) 1971-10-11
PL88879B1 (en) 1976-10-30
GB1274521A (en) 1972-05-17
DE1934809A1 (en) 1970-01-29
FR2013568A1 (en) 1970-04-03
NL6911272A (en) 1970-01-27
CH532556A (en) 1973-01-15

Similar Documents

Publication Publication Date Title
CA954512A (en) 5-phenyl-tetrazole derivatives
AU502845B2 (en) Eburnamenine derivatives
CA956312A (en) Quinuclidin-quinolinemethanol derivatives
CA781467A (en) Furochromone derivatives
CA944354A (en) Cycloalkano-quinolone derivatives
CA795330A (en) Dibenzocycloheptadiene-5-carboxamide derivatives
CA945548A (en) 2-iminobenzodiazepine derivatives
CA957382A (en) Azetidinol derivatives
AU431609B2 (en) Cycloalkano-quinolone derivatives
CA795792A (en) Benzamidobenzanilide derivatives
CA784232A (en) Thiaxanthene-1-oxide derivatives
CA781930A (en) Bromopyridazone derivatives
CA785756A (en) Hydroretrocortin derivatives
CA796314A (en) Benzo-cyclohepta-thiophene derivatives
CA796733A (en) Gonatriene derivatives
CA797855A (en) Isoindolenine derivatives
CA799484A (en) Triphenylhaloethylene derivatives
CA801013A (en) 16-alkyl-progesterone derivatives
AU442136B2 (en) Benzothiopyranopyridine derivatives
CA793336A (en) Benzocycloheptathiophene derivatives
AU440270B2 (en) Diphenylmethoxyethylamino derivatives
AU438969B2 (en) Diazpine derivatives
AU435189B2 (en) Phthaloyl-benzopyrrocoline derivatives
CA801054A (en) 3-hydroxyisoxazole derivatives
AU429809B2 (en) 5-nitrofuran derivatives